Endocrine resistance in hormone-responsive breast cancer: mechanisms and therapeutic strategies

The majority of breast cancers may be considered hormone responsive due to expression of hormone receptors (HR+). Although endocrine therapy is always considered for advanced HR+ breast cancer, the emergence of resistance is inevitable over time and is present from the start in a proportion of patie...

Ausführliche Beschreibung